A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT02753127 · COMPLETED
Trial details
- NCT number
- NCT02753127
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-04-28
- Enrollment
- 1253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.